Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer

N Harbeck, RE Kates, M Schmitt, K Gauger, M Kiechle, F Jänicke, C Thomssen, Maxime Look, John Foekens

Research output: Contribution to journalArticleAcademic

90 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)348-352
Number of pages5
JournalClinical Breast Cancer
Issue number5
Publication statusPublished - 2004

Cite this